A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.
G R Warnick,John J. Albers +1 more
Reads0
Chats0
TLDR
Determination of the extent of the unprecipitated apoB-associated lipoproteins by sensitive radioimmunoassay and of the amount of precipitated high density lipoprotein by radial immunodiffusion assay of apolipoproteins A-I and A-II at various heparin and Mn(2+) concentrations indicated that the usual Heparin level was adequate.About:
This article is published in Journal of Lipid Research.The article was published on 1978-01-01 and is currently open access. It has received 1297 citations till now. The article focuses on the topics: High-density lipoprotein & Apolipoprotein B.read more
Citations
More filters
Journal ArticleDOI
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* trial)
Peter B. Jones,Michael H. Davidson,Evan A. Stein,Harold E. Bays,James M. McKenney,Elinor Miller,Valerie A. Cain,James W. Blasetto +7 more
TL;DR: In this paper, a 6-week, parallel-group, open-label, randomized, multicenter trial was conducted to compare rosuvastatin with comparators for other lipid modifications and achievement of National Cholesterol Education Program Adult Treatment Panel III and Joint European Task Force LDL cholesterol goals.
Journal ArticleDOI
Vascular risk factors and diabetic neuropathy
Solomon Tesfaye,Nish Chaturvedi,Simon E.M Eaton,John D. Ward,Christos Manes,Constantin Ionescu-Tirgoviste,Daniel R. Witte,John H. Fuller +7 more
TL;DR: It is indicated that, apart from glycemic control, the incidence of neuropathy is associated with potentially modifiable cardiovascular risk factors, including a raised triglyceride level, body-mass index, smoking, and hypertension.
Journal ArticleDOI
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.
Sylvia Wassertheil-Smoller,Susan L. Hendrix,Marian C. Limacher,Gerardo Heiss,Charles Kooperberg,Alison E. Baird,Theodore A. Kotchen,J. David Curb,Henry R. Black,Jacques E. Rossouw,Aaron K. Aragaki,Monika M. Safford,Evan A. Stein,Somchai Laowattana,W. Jerry Mysiw +14 more
TL;DR: Excess risk for all strokes attributed to estrogen plus progestin appeared to be present in all subgroups of women examined, and excess risk of all stroke was apparent in all age groups, in all categories of baseline stroke risk, and in women with and without hypertension, prior history of cardiovascular disease, use of hormones, statins, or aspirin.
Journal ArticleDOI
Comparison of the Atkins, Zone, Ornish, and LEARN Diets for Change in Weight and Related Risk Factors Among Overweight Premenopausal Women: The A TO Z Weight Loss Study: A Randomized Trial
Christopher D. Gardner,Alexandre Kiazand,Sofiya Alhassan,Soowon Kim,Randall S. Stafford,Raymond R. Balise,Helena Chmura Kraemer,Abby C. King +7 more
TL;DR: In this study, premenopausal overweight and obese women assigned to follow the Atkins diet, which had the lowest carbohydrate intake, lost more weight and experienced more favorable overall metabolic effects at 12 months than women assignedto follow the Zone, Ornish, or LEARN diets.
Journal ArticleDOI
Menopause and Risk Factors for Coronary Heart Disease
Karen A. Matthews,Elaine N. Meilahn,Lewis H. Kuller,Sheryl F. Kelsey,Arlene W. Caggiula,Rena R. Wing +5 more
TL;DR: It is suggested that a natural menopause has an unfavorable effect on lipid metabolism, which may contribute to an increase in the risk of coronary disease.
References
More filters
Journal ArticleDOI
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
TL;DR: A method for estimating the cholesterol content of the serum low-density lipoprotein fraction (Sf0-20) is presented and comparison of this suggested procedure with the more direct procedure, in which the ultracentrifuge is used, yielded correlation coefficients of .94 to .99.
Journal ArticleDOI
Plasma-high-density-lipoprotein concentration and development of ischæmic heart-disease
G.J Miller,N.E Miller +1 more
TL;DR: The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins, and it is proposed that a reduction of plasma-H.H.L.D., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease, by impairing the clearance of cholesterol from the arterial wall.
Journal ArticleDOI
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
TL;DR: With a single preparative ultracentrifugation, immunologically pure high density lipoproteins can be isolated from large volumes of serum.
Journal ArticleDOI
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.
TL;DR: During the first 24 h after injection of 125I-labeled very low density lipoprotein to humans, the decay rate of low densitylipoprotein apoprotein from very lowdensity lipoproteins was faster than that of apolipoprotein glutamic acid, apoipoprotein alanine1 and apolipropoteinAlanine2.
Journal ArticleDOI
Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.
TL;DR: The inverse relation of alpha cholesterol of prevalence of coronary heart disease was independent of beta cholesterol, obesity, and other factors, and the need for further evaluation of the protective effect of the alpha lipoprotein fraction on the development of coronaryHeart disease is suggested.
Related Papers (5)
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
Quantitative Determination of Serum Triglycerides by the Use of Enzymes
Giovanni Bucolo,Harold David +1 more
A simple method for the isolation and purification of total lipides from animal tissues.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more